L. He et al. / Tetrahedron: Asymmetry 18 (2007) 265–270
269
4.3.6. 2-[Hydroxy-(2-fluoro-phenyl)-methyl]-cyclohexanone
7af. Yield: 92%; anti/syn: = 97:3 anti-diastereomer,
2.38–2.45 (m, 1H), 2.60 (m, 1H), 3.93 (br s, 1H), 4.73 (d,
J = 8.8 Hz, 1H), 7.16 (d, J = 8.0 Hz, 4H); 7.19 (d,
J = 8.0 Hz, 4H); 13C NMR (75 MHz, CDCl3): d (ppm)
21.120, 24.68, 27.794, 30.836, 42.635, 57.389, 74.492,
126.887, 129.015, 137.519, 137.903, 215.673; Enantiomeric
excess: 99% determined by HPLC (Daicel Chiralpak AS,
i-PrOH/hexane = 30:70), UV 254 nm, flow rate: 1.0 mL/
min, tRmajor = 6.137 min; tRminor = 7.047 min.
20
½aꢁD ¼ ꢀ14:2 (c 0.5, CH3CO2Et); 1H NMR (300 MHz,
CDCl3): d (ppm) 1.44–1.65 (m, 4H), 1.77 (m, 1H), 2.10
(m, 1H), 2.32 (m, 2H), 2.66 (m, 1H), 3.99 (d, J = 3.2 Hz,
1H), 5.14 (dd, J = 2.9, 8.6 Hz, 1H), 6.96–7.02 (m, 1H),
7.14–7.17 (m, 1H), 7.23–7.26 (m, 1H), 7.46 (m, 1H); 13C
NMR (75 MHz, CDCl3): d (ppm) 24.63, 27.68, 30.21,
42.52, 56.99, 67.94, 114.91 (J = 2.2 Hz), 124.35
(J = 2.9 Hz), 128.22 (J = 3.9 Hz), 129.05 (J = 8.2 Hz),
158.40, 161.65, 215.18; IR (neat) 3512, 2940, 2862, 1698,
1617, 1587, 1492, 1452, 1222, 824, 757; Enantiomeric
excess: >99% determined by HPLC (Daicel Chiralpak
OD, i-PrOH/hexane = 10:90), UV 254 nm, flow rate
1.0 mL/min, tRminor = 6.557 min; tRmajor = 8.106 min.
4.3.11. 2-[Hydroxy-isopropyl-methyl]-cyclohexanone 7ak.
20
Yield: 38%; anti/syn: >99:1; anti-diastereomer, ½aꢁD
¼
1
ꢀ1:2 (c 0.5, CH3CO2Et); H NMR (300 MHz, CDCl3): d
(ppm) 0.85–0.94 (m, 3H), 1.62–2.04 (m, 5H), 2.30 (m,
2H), 2.34–2.42 (m, 3H), 3.14 (br s, 1H), 3.48 (dd, J = 3.9,
7.4 Hz, 1H); 13C NMR (75 MHz, CDCl3): d (ppm)
15.102, 20.043, 24.870, 26.759, 29.090, 30.570, 42.825,
53.565, 75.571, 216.069; IR (Neat): 3541, 2957, 2953,
2870, 1695, 1616, 1398, 1129, 993 cmꢀ1; Enantiomeric
excess: >99%, determined by chiral GC analysis (CP
CHIRASIL-DEX), Inject Temp 240 °C, Column Temp
100 °C, FID Oven Temp 260 °C, Inlet Pressure 13Psi,
tRmajor = 20.535 min; tRminor = 21.077 min.
4.3.7. 2-[Hydroxy-(2,6-2-chloro-phenyl)-methyl]-cyclohexa-
none 7ag. Yield: 91%; anti/syn: >99:1; anti-diastereomer,
20
½aꢁD ¼ ꢀ80:2 (c 0.5, CH3CO2Et); 1H NMR (300 MHz,
CDCl3): d (ppm) 1.24–1.68 (m, 4H), 1.71 (m, 1H), 2.03
(m, 1H), 2.38–2.49 (m, 2H), 3.47 (m, 1H), 3.65 (d,
J = 4.2 Hz, 1H), 5.80 (dd, J1 = 4.2 Hz, J2 = 9.6 Hz, 1H),
7.11–7.31 (m, 3H), 13C NMR (75 MHz, CDCl3): d (ppm)
24.655, 27.583, 29.822, 42.403, 53.610, 70.541, 129.302,
134.685, 135.650, 214.364; IR (neat): 3564, 3060, 2964,
2937, 2861, 1695, 1560, 1438, 1131, 794, 762 cmꢀ1; Enan-
tiomeric excess: >99%, determined by HPLC (Daicel Chir-
alpak OJ, i-PrOH/hexane = 5:95), UV 254 nm, flow rate:
1.0 mL/min, tRminor = 9.14 min; tRmajor = 10.30 min.
4.3.12. 2-[Hydroxy-cyclohexyl-methyl]-cyclohexanone 7al.
20
Yield: 40%; anti/syn: >99:1; anti-diastereomer, ½aꢁD
¼
1
ꢀ48 (c 0.5, CH3CO2Et); H NMR (300 MHz, CDCl3): d
(ppm) 1.14–1.68 (m, 14H), 1.73 (m, 1H), 1.75 (m, 2H),
2.35 (m, 2H), 2.49 (m, 1H), 3.26 (br s, 1H), 3.45 (dd,
J = 3.6, 7.1 Hz, 1H); 13C NMR (75 MHz, CDCl3): d
(ppm) 24.967, 25.892, 26.253, 26.376, 26.549, 27.822,
30.308, 30.814, 39.409, 42.936, 52.823, 75.604, 216.210;
IR (Neat): 3541, 2927, 2853, 1696, 1448, 1129 cmꢀ1; Enan-
tiomeric excess: 99% determined by HPLC (Daicel Chir-
alpak AD, i-PrOH/hexane = 15:85), UV 280 nm, flow
rate 1.0 mL/min, tRmajor = 4.47 min; tRminor = 5.62 min.
4.3.8. 2-[Hydroxy-(4-chloro-phenyl)-methyl]-cyclohexanone
7ah. Yield: 71%; anti/syn: = 98:2 anti-diastereomer,
20
½aꢁD ¼ ꢀ5:0 (c 0.5, CH3CO2Et); 1H NMR (300 MHz,
CDCl3): d (ppm) 1.26–1.31 (m, 1H), 1.31–1.64 (m, 5H),
2.06 (m, 1H), 2.45–2.55 (m, 3H), 3.98 (d, J = 2.7 Hz,
1H), 4.74 (dd, J = 2.7, 8.7 Hz, 1H), 7.23 (d, J = 8.4 Hz,
2H), 7.30 (d, J = 8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d (ppm) 24.695, 27.701, 30.738, 42.647, 57.352, 74.122,
128.368, 128.520, 133.569, 139.490, 215.2; Enantiomeric
excess: 98% determined by HPLC (Daicel Chiralpak OJ,
i-PrOH/hexane = 5:95), UV 254 nm, flow rate 1.0 mL/
min, tRmajor = 10.892 min; tRminor = 12.615 min.
4.3.13. 7-[Hydroxy-(4-nitro-phenyl)-methyl]-1,4-dioxa-spiro-
[4.5]decan-8-one 7ba. Yield: 90%; anti/syn: = 98:2; anti-
20
1
diastereomer, ½aꢁD ¼ ꢀ2:8 (c 0.5, CH3CO2Et); H NMR
(300 MHz, CDCl3): d (ppm) 1.48–1.52 (m, 1H), 1.69–1.74
(m, 1H), 1.78–2.04 (m, 2H), 2.47 (m, 1H), 2.71 (m, 1H),
2.98 (m, 1H), 3.86–3.96 (m, 4H), 4.03 (d, J = 3.1 Hz,
1H), 4.90 (dd, J = 3.1, 8.1 Hz, 1H), 7.48 (d, J = 8.4 Hz,
2H), 8.19 (d, J = 8.4 Hz, 2H); 13C NMR (75 MHz, CDCl3):
d (ppm) 34.287, 37.750, 38.760, 52.918, 64.627, 73.731,
106.720, 123.552, 126.491, 127.836, 147.853, 213.132;
Enantiomeric excess: 94%, determined by HPLC (Daicel
Chiralpak AS, i-PrOH/hexane = 30:70), UV 254 nm, flow
rate 1.0 mL/min, tRminor = 12.21 min; tRmajor = 17.87 min.
4.3.9. 2-[Hydroxy-(4-bromo-phenyl)-methyl]-cyclohexanone
7ai. Yield: 60%; anti/syn: >99:1, anti-diastereomer,
20
½aꢁD ¼ ꢀ5:0 (c 0.5, CH3CO2Et); 1H NMR (300 MHz,
CDCl3): d (ppm) 1.25–1.64 (m, 4H), 1.78 (m, 1H), 2.04
(m, 1H), 2.33–2.38 (m, 1H), 2.48–2.55 (m, 2H), 3.97 (d,
J = 2.8 Hz, 1H), 4.73 (dd, J = 2.7, 8.6 Hz, 1H), 7.18 (d,
J = 8.3 Hz, 2H), 7.44 (d, J = 8.3 Hz, 2H); 13C NMR
(75 MHz, CDCl3):
d (ppm) 24.699, 27.698, 30.741,
42.646, 57.314, 74.181, 121.707, 128.724, 131.477,
140.017, 215.223; Enantiomeric excess: 96% determined
by HPLC (Daicel Chiralpak OJ, i-PrOH/hexane = 5:95),
UV 254 nm, flow rate 1.0 mL/min, tRmajor = 11.857 min;
tRminor = 13.832 min.
4.3.14. 3-[Hydroxyl-(4-nitro-phenyl)-methyl]-tetrahydrothio-
pyran-4-one 7ca. Yield: 82%; anti/syn: = 98:2; anti-diaste-
20
reomer, ½aꢁD ¼ ꢀ56 (c 0.5, CH3CO2Et); 1H NMR
(300 MHz, CDCl3): d (ppm) 1.36–1.39 (m, 1H), 1.40–1.57
(m, 1H), 1.81–1.85 (m, 1H), 2.09 (m, 1H), 2.35–2.39 (m,
1H), 2.48–2.59 (m, 2H), 4.06 (d, J = 3.1 Hz, 1H), 4.87
(dd, J = 3.1, 8.3 Hz, 1H), 7.49 (d, J = 8.7 Hz, 2H), 8.19
(d, J = 8.7 Hz, 2H); 13C NMR (75 MHz, CDCl3): d
(ppm) 30.807, 32.814, 44.755, 59.450, 73.186, 123.803,
127.775, 147.597, 147.736, 211.256; Enantiomeric excess:
97%, determined by HPLC (Daicel Chiralpak AS,
4.3.10.
2-[Hydroxy-(4-methyl-phenyl)-methyl]-cyclohexa-
none 7aj. Yield: 42%; anti/syn: >99:1; anti-diastereomer,
20
½aꢁD ¼ ꢀ3:8 (c 0.5, CH3CO2Et); 1H NMR (300 MHz,
CDCl3): d (ppm) 1.25–1.30 (m, 1H), 1.51–1.75 (m, 4H),
2.05 (m, 1H), 2.33–2.36 (m, 3H), 2.36–2.38 (m, 1H),